← Product Code [DYB](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DYB) · K012812 # CAROTID GUIDING SHEATH (K012812) _Terumo Medical Corp. · DYB · Nov 14, 2001 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DYB/K012812 ## Device Facts - **Applicant:** Terumo Medical Corp. - **Product Code:** [DYB](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DYB.md) - **Decision Date:** Nov 14, 2001 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 870.1340 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular ## Indications for Use The Carotid Guiding Sheath is intended for the introduction of interventional and diagnostic devices into the human vasculature including but not limited to the carotid arteries. ## Device Story Carotid Guiding Sheath functions as both guiding catheter and introducer sheath. Device features coil-reinforced body, radiopaque marker, and hydrophilic coating on distal 15 cm. Packaged with dilator, rotating hemostatic valve (Y-connector), and dilator retaining clip. Operated manually by clinicians to facilitate access to human vasculature, including carotid arteries. Provides conduit for interventional and diagnostic devices. Benefits patient by enabling minimally invasive vascular access. ## Clinical Evidence Bench testing only. Performance verified via penetration, kink resistance, leakage, tensile strength, and tortuous path/durability testing. Biocompatibility evaluated per ISO 10993 for externally communicating, blood-contacting devices (limited contact ≤24hrs). ## Technological Characteristics Coil-reinforced sheath; 6-7Fr sizes; 80-110 cm length; distal 15 cm hydrophilic coating; radiopaque marker. Includes dilator and rotating hemostatic valve. Sterilized per ANSI/AAMI/ISO 11135-1994 (SAL 10^-6). ## Regulatory Identification A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery. ## Predicate Devices - Super Arrow-Flex Percutaneous Sheath Introducer Set ([K924607](/device/K924607.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ # KU12812 ## NOV 1 4 2001 # SECTION II. SUMMARY OF SAFETY & EFFECTIVENESS #### A. DEVICE NAME | Proprietary Name: | Has not been established yet | |----------------------|------------------------------| | Classification Name: | Catheter Introducer | | Common Name: | Guiding Sheath | #### B. PREDICATE DEVICE The predicate device is the Super Arrow-Flex Percutaneous Sheath Introducer Set, which is manufactured by Arrow International, Inc. The Super Arrow-flex is cleared through the premarket notification process (K924607). #### C. INTENDED USE The Carotid Guiding Sheath is intended for the introduction of interventional and diagnostic devices into the human vasculature including but not limited to the carotid arteries. #### DESCRIPTION D. The Carotid Guiding Sheath is designed to perform as a guiding catheter and an introducer sheath. The sheath is coil reinforced, has a radiopaque marker and is hydrophilically coated on the distal 15 cm. It comes packaged with a dilator, a rotating hemostatic valve (Y-connector), and a dilator retaining clip. {1}------------------------------------------------ #### PRINCIPLE OF OPERATION / TECHNOLOGY E. The Carotid Guiding Sheath and the Super Arrow-Flex Percutaneous Sheath Introducer Set are operated manually or by a manual process. #### F. DESIGN / MATERIALS The Carotid Guiding Sheath use similar materials as the predicate device. Differences in materials between the two devices do not raise any new issues of safety and effectiveness. #### G. SPECIFICATIONS | Sheath Size: | 6-7Fr. | |------------------------------|-----------------------| | Nominal ID / OD: | 6Fr.: 0.087" / 0.112" | | | 7Fr.: 0.100" / 0.122" | | Sheath Length: | 80 – 110 cm | | Hydrophilic Coating: | Distal 15 cm | | Distal Shape Configurations: | Straight | #### H. PERFORMANCE The performance of the Carotid Guiding Sheath is substantially equivalent to the performance of the Super Arrow-Flex Percutaneous Sheath Introducer. The following tests were performed to demonstrate the substantial equivalence of the devices. - > Penetration - > Kink Resistance - > Leakage - Tensile Strength A - > Tortuous Path / Durability {2}------------------------------------------------ #### I. ADDITIONAL SAFETY INFORMATION Sterilization conditions have been validated in accordance with ANSI / AAMI / ISO 11135-1994 to provide a Sterility Assurance Level of 10-6. Blood contacting materials were tested in accordance with the test recommendations in the FDA General Program Memorandum #G95-1 (5/1/95): Use of International Standard ISO 10993, "Biological Evaluation of Medical Devices - Part I: Evaluation and Testing." The Carotid Guiding Sheath is categorized as "Externally Communicating Device, Circulating Blood, Limited Contact (≤24hrs)". The blood contacting materials were found to be biocompatible. Expiration dating for the Carotid Guiding Sheath will be 30 months. #### J. SUBSTANTIAL EQUIVALENCE The Carotid Guiding Sheath submitted in this 510(k) is substantially equivalent in intended use, design, principle of operation / technology, materials and performance to the Super Arrow-Flex Percutaneous Sheath Introducer Set (K924607), which is manufactured by Arrow International, Inc. Differences between the devices do not raise any issues of safety or effectiveness. Terumo's statement of substantial equivalence is done solely to comply with the requirements of the Federal Food, Drug and Cosmetic Act and is not intended whatsoever to be the basis for a patent infringement action. {3}------------------------------------------------ #### K. SUBMITTER INFORMATION ### Name and Address Terumo Medical Corporation 125 Blue Ball Rd. Elkton, MD 21921 ### Contact Person Mrs. Yuk-Ting Lewis Senior Regulatory Specialist Ph: 410-392-7213 Fax: 410-398-6079 Email: yukting.lewis@terumomedical.com ### Date Prepared August 1, 2001 {4}------------------------------------------------ Image /page/4/Picture/1 description: The image shows a logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes entwined around it. The symbol is surrounded by the words "DEPARTMENT OF HEALTH & HUMAN SERVICES" in a circular arrangement. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 NOV 1 4 2001 Ms. Yuk-Ting Lewis Senior Regulatory Specialist TERUMO Medical Corporation 125 Blue Ball Road Elkton, MD 21921 Re: K012812 Carotid Guiding Sheath Regulation Number: 870.1340 Regulation Name: Catheter introducer. Regulatory Class: II (two) Product Code: 74 DYB Dated: August 21, 2001 Received: August 22, 2001 Dear Ms. Lewis: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {5}------------------------------------------------ This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4586. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, the James E. Dillard III Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {6}------------------------------------------------ # NOV 1 4 2001 510(k) Number (if known): K012812 Carotid Guiding Sheath Device Name: Indications For Use: The Carotid Guiding Sheath is intended for the introduction of interventional and diagnostic devices into the human vasculature including but not limited to the carotid arteries. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter Use (Optional Format 1-2-96) Division of Cardiovas 510(k) Number K012817 --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DYB/K012812](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DYB/K012812) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com